Francois Lebel, Executive Vice President R&D at ZIOPHARM ONCOLOGY INC (ZIOP), sold 50,000 shares at $10.12 ($506K) on 2015-06-09, disclosed to the SEC on 2015-06-11.
Open-market sale of $506k ZIOP by Executive Vice President R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SPPI | SELL | 2022-03-16 | $36K | — | Filing → |
| SPPI | SELL | 2022-02-24 | $19K | — | Filing → |
| SPPI | SELL | 2021-11-10 | $29K | — | Filing → |